Everything

2024

Billion

<div>
 <h3 id="key-takeaways">Key takeaways</h3>
 <ul>
 <li>Two medical technology businesses reportedly agreed on merger economics</li>
 <li>A leadership dispute ended negotiations over the $34 billion combination</li>
 <li>The failed deal demonstrates how corporate control shapes mergers</li>
 </ul>
 Two medical technology companies reportedly agreed on the financial terms of a $34 billion merger. They had negotiated ownership, valuations and even a multibillion-dollar payment. But the transaction fell apart over a question neither side would compromise on: who would become CEO?
 The proposed combination involved Johnson &amp;amp; Johnson's orthopaedics business, DePuy Synthes, and British medical equipment manufacturer Smith &amp;amp; Nephew. According to an <a href="https://www.ft.com/content/e114059c-308d-4d8e-8127-f88b0faca879" rel="noopener noreferrer nofollow">October 23 Financial Times investigation</a>, negotiations collapsed just weeks before a planned announcement.
 It was a reminder that even enormous <a href="https://coinpaper.com/36900/david-ellison-warns-of-layoffs-after-110-billion-paramount-warner-bros-deal" rel="noopener noreferrer nofollow">corporate mergers</a> depend on decisions that cannot always be settled through financial calculations.A $34 Billion Deal With Almost Everything Agreed 
 Smith &amp;amp; Nephew approached Johnson &amp;amp; Johnson earlier in 2026 about combining its business with DePuy Synthes, one of the world's largest manufacturers of artificial joints and orthopaedic equipment.
 The proposed transaction valued the J&amp;amp;J division at approximately $22 billion, compared with Smith &amp;amp; Nephew's roughly $12.6 billion stock-market valuation.
 Under the reported structure, J&amp;amp;J shareholders would have owned 50.1% of the combined company, giving them a narrow majority. Smith &amp;amp; Nephew shareholders would have controlled the remaining 49.9%.
 Smith &amp;amp; Nephew would also have arranged approximately $10 billion in debt financing to fund a payment to J&amp;amp;J, helping balance the transaction's different business valuations.
 The transaction could have united complementary hip and knee replacement portfolios while giving both businesses greater scale.
 For Smith &amp;amp; Nephew, which had faced slowing growth and shareholder pressure, the combination offered a potentially transformative alternative to its existing strategy.
 But as other <a href="https://coinpaper.com/14424/solana-treasury-firm-solmate-scraps-rockaway-x-merger-prioritizes-capital-efficiency" rel="noopener noreferrer nofollow">abandoned mergers</a> illustrate, financial logic does not guarantee agreement on the final transaction.The CEO Who Left in 2019 Returned to the Negotiating Table 
 The disagreement centered on two executives: Namal Nawana and Deepak Nath.
 Nawana had served as Smith &amp;amp; Nephew's CEO for approximately 18 months before leaving in 2019 following a compensation dispute. Six years later, he joined J&amp;amp;J to lead DePuy Synthes through its planned separation.
 J&amp;amp;J wanted Nawana to become chief executive of the combined company. Smith &amp;amp; Nephew, however, insisted that its current CEO, Deepak Nath, retain the top position, according to people familiar with the negotiations.
 Chairman Rupert Soames reportedly made Nath's appointment a condition of the deal.
 The dispute demonstrates why <a href="https://coinpaper.com/32867/tesla-stock-under-pressure-as-spacex-merger-talk-gains-momentum" rel="noopener noreferrer nofollow">corporate governance</a> can determine the outcome of transactions worth billions.
 A CEO influences strategy, executive appointments, investment priorities and post-merger integration. Even when shareholders agree on ownership percentages, the identity of the person exercising day-to-day authority can remain contentious.
 That question becomes especially difficult when two management teams have competing visions for a business.What Happens After a $34 Billion Merger Fails? 
 Johnson &amp;amp; Johnson had already announced plans to separate DePuy Synthes in October 2025, with the business generating approximately $9.2 billion in 2024 sales.
 Following the failed negotiations, J&amp;amp;J indicated that it was leaning toward a standalone spinoff instead.
 Smith &amp;amp; Nephew faces a different challenge: improving performance independently while answering shareholders who may question whether rejecting the proposed leadership structure sacrificed a valuable strategic opportunity.
 The episode reflects the importance of <a href="https://coinpaper.com/12790/y-zi-labs-moves-to-seize-control-after-cea-s-crypto-pivot-crumbles" rel="noopener noreferrer nofollow">shareholder influence</a> and board-level control when corporate strategies collide.
 It also shows why a seemingly attractive <a href="https://coinpaper.com/16897/gme-stock-forecast-declines-amid-gamestop-ceo-ryan-cohen-s-e-bay-suspension" rel="noopener noreferrer nofollow">takeover proposal</a> can fail before investors ever receive a formal offer.
</div>

A $34 Billion Merger Collapsed Because Two Companies Couldn't Agree on One CEO

Table of Contents

Coinpaper.com

Other articles published on Oct 26, 2026

Join our free newsletter for daily crypto updates!